Neil Ranasinghe (BA) is the parent of a child who was diagnosed with leukaemia in 2003 when she was 4 years old. She is now an adult and graduated from university in 2023.  Since her daughter was on treatment he has been involved with a number of cancer charities and organisations, contributing his expertise as a Technical Author, his degree in English, and his leadership capabilities. Outside his voluntary activities, Neil is a Senior Technical Author at the London Stock Exchange Group.

Neil is a co-founder of a group of parents (PORT) that reviews documentation for parents and patients when asked to join a paediatric oncology clinical trial. PORT has reviewed documentation for over 30 clinical trials and advised on aspects of trials from a parent’s perspective. He is also lay representative on a number of paediatric oncology clinical trials and research projects in the UK.

Currently, he is active in a number of different organisations that are involved in either advocating for children with cancer in low resources settings, or collaborations between institutions in high income countries and hospitals treating children with cancer in low and middle income countries.

Neil is active in the SIOP Global Health Network (GHN), he has been involved in the SIOP Global Mapping programme since the start in 2018, and works closely with the Chair of the programme. The data is being used and requested in Latin America, and data collection across Asia is well underway.

Neil was co-chair of SIOP PODC Education and Training Committee Working Group (also known as POINTE). Neil was also a member of the SIOP Education and Training Committee, and the SIOP GHN CSG.

If you fancy a running partner in central London then Neil is your man, and he would love to hear from you.